Last reviewed · How we verify
Silver Sulfadiazine Cream 1% — Competitive Intelligence Brief
phase 3
Topical antibacterial agent
Dermatology
Small molecule
Live · refreshed every 30 min
Target snapshot
Silver Sulfadiazine Cream 1% (Silver Sulfadiazine Cream 1%) — Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara. Silver sulfadiazine cream acts as a topical antibacterial agent, inhibiting bacterial growth and preventing infection in burns and wounds.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Silver Sulfadiazine Cream 1% TARGET | Silver Sulfadiazine Cream 1% | Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara | phase 3 | Topical antibacterial agent |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Topical antibacterial agent class)
- Nucleo De Pesquisa E Desenvolvimento De Medicamentos Da Universidade Federal Do Ceara · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Silver Sulfadiazine Cream 1% CI watch — RSS
- Silver Sulfadiazine Cream 1% CI watch — Atom
- Silver Sulfadiazine Cream 1% CI watch — JSON
- Silver Sulfadiazine Cream 1% alone — RSS
- Whole Topical antibacterial agent class — RSS
Cite this brief
Drug Landscape (2026). Silver Sulfadiazine Cream 1% — Competitive Intelligence Brief. https://druglandscape.com/ci/silver-sulfadiazine-cream-1. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab